Livalo Tablet, Film Coated
Pricing Report NDC 66869-204-90

Current NADAC: $10.20605 per EA · Effective Sep 23, 2026 · Est. package price $918.54 (90 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Livalo (NDC 66869-204-90) is $10.20605 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Kowa Pharmaceuticals America, Inc., this medication is distributed in a 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$10.20605
Per EA

Effective Date
Sep 23, 2026
Billable Units
90 EA
Estimated Package Price
$918.54
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING
Generic Benchmark
The generic equivalent rate is $0.95425 (Effective: Sep 23, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.83929 to $10.24016 per EA. Over this 12 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.8393 - $10.2402
Market Volatility
111.60% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $10.20605 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $10.20449 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $10.20618 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $10.19326 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $10.19341 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $10.20673 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $10.20927 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $10.20925 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $10.19661 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $10.19852 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $10.20946 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $10.20650 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026